Biomarkers play a vital role in diagnosis and drug discovery. The reports in this category cover the markets for biomarker applications, technologies, products, and services. The biomarker applications segment covers markets such as personalized m ....see more
The biobanking market is expected to reach USD 2.69 billion by 2022 from USD 1.72 billion in 2016 at a CAGR of 7.8%. The base year for this study is 2016. The equipment segment is estimated to account for the largest share of the biobanking market in 2017. This is primarily attributed to the increasing number of biobanks and rising number of biosamples around the world, due to which the demand for equipment remains high.